Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine.

Abstract

Acute hepatitis E virus infection during pregnancy has a high fatality rate in developing countries. Little data are available on chronic infection in pregnant women. We report a case of chronic hepatitis E during treatment with infliximab and azathioprine, without adverse event during pregnancy and with spontaneous resolution after delivery.

• Authors: Caroline Charre, Christophe Ramière, Jérôme Dumortier, Florence Abravanel, Sébastien Lhomme, Rodica Gincul, Caroline Scholtès
• Journal: Emerging infectious diseases (Emerg Infect Dis) Vol. 24 Issue 5 Pg. 941-943 (05 2018) ISSN: 1080-6059 [Electronic] United States
• PMID: 29664396 (Publication Type: Case Reports, Letter)

Chemical References

• RNA, Viral
• Infliximab
• Azathioprine

Topics

• Adult
• Azathioprine (therapeutic use)
• Colitis, Ulcerative (drug therapy)
• Female
• Genotype
• Hepatitis E (virology)
• Hepatitis E virus (genetics)
• Humans
• Infliximab (therapeutic use)
• Pregnancy
• Pregnancy Outcome
• RNA, Viral (blood)
• Viral Load